Seegene, Stock Price -1.93% at This Time... 165,596 Shares Net Sold by Individuals in the Last 5 Days

As of 10:32 AM on the 18th, Seegene is trading at 208,400 KRW, down 1.93% from the previous day. The trading volume is 227,951 shares, which is about 35.22% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On December 17, Hana Financial Investment researcher Sun Min-jung stated, "November's diagnostic kit export amount reached an all-time high. The diagnostic setup established by Seegene automates the entire process from nucleic acid extraction to gene amplification and final data output, enabling fast and prompt results. Thanks to this convenience and accuracy, equipment sales have steadily occurred, and the increase in equipment sales has led to an increase in reagent sales, allowing Seegene's diagnostic kit exports to maintain high growth. They are also developing a COVID-19 diagnostic kit with increased sensitivity suitable for saliva testing." She set Seegene's target price at 370,000 KRW.

Over the past five days, individual investors have net sold 165,596 shares of Seegene, while foreigners and institutions have net bought 159,895 shares and 3,888 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.